Top Menu

Archive | Ehrlich on Creative

Bob Ehrlich

Cosentyx Lasts

It is great to have a campaign that lasts. Too many advertisers change their ad executions too quickly. Consumers benefit by seeing a good campaign kept on air. It takes a long time to establish brand recall and keeping continuity of a campaign helps with brand and ad awareness.Cosentyx, from Novartis, is one of my […]

Continue Reading 0
Bob Ehrlich

Rinvoq A New Approach

Rinvoq, a new drug for Rheumatoid Arthritis (RA), is on my creative radar this week. The AbbVie drug has an interestingĀ 60 second spotĀ that debuted earlier this year. There are several elements that I think are done quite well. First, the benefits are well explained with a voice over and supers for emphasis. Second, there is […]

Continue Reading 0
Bob Ehrlich

A Time For Hope Through Science

Dear DTC Colleague,The first campaign I have chosen to discuss is corporate. Normally I will focus on brand or disease information campaigns. In this case and at this time, however, it is highly appropriate to discuss the new Pfizer spot on research for COVID-19 which first aired April 15. The campaign is a powerful statement on what […]

Continue Reading 0